Form D · Biotechnology
FIVE PRIME THERAPEUTICS INC
South San Francisco, CA · CIK 0001175505
Offering snapshot reported Mar 26, 2014 · SEC filing
- Reported sold
- $21M Offering amount: $21M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 19, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2014 | Initial | $21,040,488 | No comparison | 1 | SEC filing |
| Apr 20, 2012 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Sep 16, 2010 | Initial | $7,499,999 | No comparison | 1 | SEC filing |
| May 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 26, 2005 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-214271
Source: Form D, filed Mar 26, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian G Atwood | Director |
| Marc L. Belsky | Executive |
| Franklin Berger | Director |
| Franklin M. Berger, Cfa | Director |
| James Blair | Director |
| Brook Byers | Director |
| Lauretta Cesario | Executive |
| Fred Cohen | Director |
| Fred E. Cohen, M.D., D.Phil. | Director |
| Robert Lee Douglas | Director |
| R. Lee Douglas | Director |
| Julia P. Gregory | Director, Executive |
| Julie Hambleton, M.D. | Executive |
| Peder K Jensen | Director |
| Peder K. Jensen, M.D. | Director |
| W. Michael Kavanaugh | Executive |
| W. Michael Kavanaugh, M.D. | Executive |
| Aron M. Knickerbocker | Director, Executive |
| Mark D. Mc Dade | Director |
| Francis W. Sarena | Executive |
| Lewis T. Williams | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Two Corporate Drive
South San Francisco, CA, 94080
South San Francisco, CA, 94080